glycyrrhizic acid has been researched along with indomethacin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Adachi, I; Furusawa, K; Ito, T; Kato, A; Onikata, S; Tomohara, K | 1 |
| Abe, H; Adachi, I; Horino, Y; Kesamaru, H; Nose, T; Suyama, K; Tomohara, K | 1 |
| Chen, CF; Tsai, TH | 1 |
| Fujita, T | 1 |
| Li, YX; Ma, L; Niu, Y; Niu, YT; Shi, GJ; Sun, T; Wang, HL; Wu, J; Yu, JQ; Zheng, J | 1 |
7 other study(ies) available for glycyrrhizic acid and indomethacin
| Article | Year |
|---|---|
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Interpreting the behavior of concentration-response curves of hyaluronidase inhibitors under DMSO-perturbed assay conditions.
Topics: Chondroitin Sulfates; Cromolyn Sodium; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Glycyrrhizic Acid; Hyaluronoglucosaminidase; Molecular Structure; Structure-Activity Relationship | 2016 |
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
Topics: | 2019 |
Determination of glycyrrhizin in rabbit plasma by high-performance liquid chromatography with photodiode-array ultraviolet detection and its pharmacokinetics application.
Topics: Animals; Chromatography, High Pressure Liquid; Glycyrrhetinic Acid; Glycyrrhizic Acid; Indicators and Reagents; Indomethacin; Injections, Intravenous; Male; Models, Biological; Rabbits; Spectrophotometry, Ultraviolet | 1992 |
[Frequency of various types of secondary hypertension and pathogenic mechanisms].
Topics: Adrenal Gland Neoplasms; Cushing Syndrome; Diagnosis, Differential; Glycyrrhetinic Acid; Glycyrrhizic Acid; Humans; Hyperaldosteronism; Hypertension; Hypertension, Renovascular; Indomethacin; Kidney Diseases; Pheochromocytoma | 1990 |
Observing Anti-inflammatory and Anti-nociceptive Activities of Glycyrrhizin Through Regulating COX-2 and Pro-inflammatory Cytokines Expressions in Mice.
Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Capillary Permeability; Carrageenan; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Formaldehyde; Glycyrrhizic Acid; Indomethacin; Inflammation; Inflammation Mediators; Male; Mice, Inbred ICR; Motor Activity; Nitric Oxide Synthase Type II; Nociceptive Pain; Pain Threshold; Psychomotor Performance; Time Factors; Xylenes | 2015 |